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Diagnosis of pulmonary hypertension is often delayed because
of nonspecific symptoms (5), which may be even more so regarding
exercise-induced pulmonary hypertension. Therefore, PAP mea-
surement during exercise may be helpful in subjects with unex-
plained dyspnea on exertion, some of which are considered to have
diastolic heart failure. High altitude pulmonary edema shows that
it is not mandatory to have a significantly elevated left-sided filling
pressure to develop pulmonary edema, but that alterations within
the pulmonary vasculature can be the causative factor (6). Pulmo-
nary vascular hyperreagibility in response to hypoxia (i.e., HAPE
susceptibility) may also explain why some patients with pulmonary
diseases develop pulmonary hypertension whereas others do not. In
patients with chronic hypoxia, HAPE susceptibility might facili-
tate pulmonary vasoconstriction.
Since this study does not address pathogenetic issues, we are
unable to shed further light on the underlying cause of HAPE
susceptibility. Importantly, this study provides preliminary results
only. The small number of subjects included contains some risk of
a false-positive finding. Furthermore, whether some of the
HAPE-susceptible subjects presented will actually develop clinical
signs of pulmonary hypertension remains speculative. A long-term
follow-up study is necessary to address this question.
Nevertheless, the relatively high prevalence of HAPE suscepti-
bility and the fact that more than half of the HAPE-susceptible
subjects developed pulmonary hypertension at a workload corre-
sponding to daily activities with structural changes indicating
right-sided cardiac pressure overload highlight the need for more
frequent consideration of exercise-induced pulmonary hyperten-
sion as potential cause of exertional dyspnea.
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Letters to the Editor
Left Atrial Dimension
in Stress Echocardiography
We read with interest the recent study by Bangalore et al. (1)
evaluating the prognostic significance of left atrial (LA) enlarge-
ment in patients undergoing stress echocardiography. The authors
demonstrate that left atrial dimension provides incremental prog-
nostic significance in patients referred for stress echocardiography,
irrespective of the presence of inducible ischemia. Although we
applaud the authors for highlighting the importance of left atrial
enlargement in this patient population, there are several method-
ologic concerns which profoundly limit the applicability of their
findings to clinical practice.
First, the use of M-mode linear dimension to measure left atrial
volume is inaccurate and varies widely among individual readers
(2). We have previously shown that left atrial volume is most
Figure 1 Individual Response of pTR
Individual response of pressure gradient across tricuspid valve (pTR) at low
altitude from rest to low-intensity exercise (Ex1  20% and Ex2  40%,
respectively, of previously tested maximal exercise capacity) in high altitude
pulmonary edema (HAPE)-susceptible subjects (right) compared with control
subjects (non-HAPE). Red dotted lines indicate approximate upper limit of
normal during exercise.
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accurately estimated by 2-dimensional (2D) echocardiography
using biplane methods (area–length or method of discs) (3); this
approach is recommended by the American Society of Echocar-
diography for use in clinical trials (4). Left atrial dimension
consistently underestimates left atrial volume and is therefore a
specific but insensitive test for left atrial enlargement (5). As such,
a significant proportion of patients with true left atrial enlargement
were likely categorized as normal. The authors’ qualification that
“unidimensional measurement is still the most common method
worldwide to quantify LA size,” although true, is not adequate
justification for the investigative use of an inferior measurement. A
suitable analogy would be the use of urinary dipstick testing rather
than serum glucose measurement to determine the prevalence of
diabetes in a study population.
Second, the resting ejection fraction used in the study analysis
was based on visual estimation or “eyeballing.” This technique is
not only inaccurate in determining ejection fraction compared with
2D measurement techniques, but also suffers from wide interob-
server variability and poor reproducibility (6). Moreover, the mean
ejection fraction in the patients with dilated left atria was 48%,
suggesting established systolic dysfunction at baseline rather than
“relatively preserved [left ventricular] ejection fraction,” as the
authors contend.
Third, the authors did not report or correct for Doppler indices
of diastolic dysfunction in the multivariate analysis. If, as they
suggest, left atrial size is a marker of the severity and duration of
diastolic function, then the independent prognostic value of left
atrial enlargement cannot be established without taking diastolic
dysfunction into account.
Given these methodologic concerns, the authors’ conclusion
that left atrial size should be routinely incorporated in the
prognostic interpretation of stress testing is not justified and
furthermore would be unlikely to impact clinical decision making.
For example, in the presence of a positive stress echocardiogram it
is doubtful that coronary angiography would be averted because of
the single measurement of a small left atrial dimension. Conversely
an enlarged left atrial dimension in the setting of a normal stress
echocardiogram is of unclear significance and would not, on its
own, merit further invasive workup.
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Reply
Although we agree in principle with the views of Dr. Farzaneh-Far
and colleagues on the relative value of left atrial (LA) dimension
versus volume measurements (as we have acknowledge in the study
limitations), there is paucity of data of using any kind of LA size
measurement during stress echocardiography. The authors claim
that “left atrial volume is most accurately estimated by 2D
echocardiography using biplane methods (area-length or method
of discs)”. Studies have shown that true 3-dimensional (3D)
echocardiographic methods or simplified 3D reconstruction
method correlate better with magnetic resonance imaging-derived
LA volumes (1,2) at the expense of increased complexity of
measurement and time. Although the limitations of a LA dimen-
sion measurement are well known, given its simplicity, speed, and
reproducibility, this measure might be better applicable to patients
undergoing stress echocardiography.
Although American Society of Echocardiography recommends
using LA volume for use in clinical trials, LA dimension is still the
most commonly used measure in large multicenter clinical trials.
In the Cardiovascular Health Study of 5,888 men and women,
LA dimension was a significant predictor of future heart failure
after controlling for baseline risk factors (3). Similarly, in the
Framingham Heart Study (4) and the SPAF (Stroke Prevention in
Atrial Fibrillation) trial (5), LA dimension was related to strokes
and death in the former and to thromboembolic events (e.g.,
strokes and transient ischemic attacks) in the latter. Even in the
more recent trials like the LIFE (Losartan Intervention for
Endpoint reduction in hypertension) trial, LA diameter/height
predicted risk of cardiovascular events independent of other clinical
risk factors in hypertensive patients with left ventricular hypertro-
phy (6). In our study we have shown that there was strong
interobserver (interclass correlation [ICC]  0.977) and intraob-
server (ICC  0.980) correlations for the measurement of LA
dimension (7).
We have discussed the relative value of using LA size as a
marker of diastolic function on the basis of prior studies—it
reflects the chronicity and magnitude of the increased left ventric-
ular filling pressure (8) and is thus a marker of the severity and
duration of diastolic dysfunction (9). It has been suggested (10)
that Doppler indexes of diastolic function reflect filling pressures at
1 point in time and hence LA size might be a better marker,
because it represents the chronicity of diastolic function. Given this
data from previous studies, we did not correct for Doppler indexes
of diastolic dysfunction in the multivariate analysis.
With regard to the accuracy of visually estimated left ventricular
ejection fraction, prior studies have shown strong correlation of
visually estimated left ventricular ejection fraction with radionu-
clide angiography (11).
Finally, although we do agree that “enlarged left atrial dimen-
sion in the setting of a normal stress echocardiogram is of unclear
significance, and would not, on its own, merit further invasive
workup,” it should be emphasized that, in the setting of a normal
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